HNF4A通过抑制NCOA4介导的费里替诺来改善急性肝衰竭

Weiyan Yu1, Caiyan Zhao2

  • 1Department of Infectious Diseases, The Third Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Scientific reports
|August 13, 2025
PubMed
概括

核受体协活性剂4 (NCOA4) 在急性肝衰竭 (ALF) 中被上调,促进铁亡. 抑制NCOA4可以缓解肝损伤,而HNF4A-NCOA4轴为ALF提供了潜在的治疗点.